Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2010 1
2011 2
2012 2
2014 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Prostate cancer: a review of active surveillance.
Lund L, Svolgaard N, Poulsen MH. Lund L, et al. Among authors: svolgaard n. Res Rep Urol. 2014 Aug 16;6:107-12. doi: 10.2147/RRU.S41653. eCollection 2014. Res Rep Urol. 2014. PMID: 25202685 Free PMC article. Review.
[Metastasis in testis from prostate cancer].
Mortensen MA, Engvad B, Geertsen L, Svolgaard N, Lund L. Mortensen MA, et al. Among authors: svolgaard n. Ugeskr Laeger. 2014 Mar 24;176(13):V10130632. Ugeskr Laeger. 2014. PMID: 25349932 Free article. Danish.
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial.
Hedlund PO, Johansson R, Damber JE, Hagerman I, Henriksson P, Iversen P, Klarskov P, Mogensen P, Rasmussen F, Varenhorst E; SPCG-5 STUDY GROUP. Hedlund PO, et al. Scand J Urol Nephrol. 2011 Nov;45(5):346-53. doi: 10.3109/00365599.2011.585820. Epub 2011 May 31. Scand J Urol Nephrol. 2011. PMID: 21627403 Clinical Trial.
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
Hedlund PO, Damber JE, Hagerman I, Haukaas S, Henriksson P, Iversen P, Johansson R, Klarskov P, Lundbeck F, Rasmussen F, Varenhorst E, Viitanen J; SPCG-5 Study Group. Hedlund PO, et al. Scand J Urol Nephrol. 2008;42(3):220-9. doi: 10.1080/00365590801943274. Scand J Urol Nephrol. 2008. PMID: 18432528 Clinical Trial.
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Poulsen MH, Bouchelouche K, Gerke O, Petersen H, Svolgaard B, Marcussen N, Svolgaard N, Ogren M, Vach W, Høilund-Carlsen PF, Geertsen U, Walter S. Poulsen MH, et al. Among authors: svolgaard n. BJU Int. 2010 Sep;106(5):639-43; discussion 644. doi: 10.1111/j.1464-410X.2009.09191.x. BJU Int. 2010. PMID: 20089104
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S. Poulsen MH, et al. Among authors: svolgaard n. BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23. BJU Int. 2012. PMID: 22520686